Cargando…
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
Mitochondrial serine hydroxyl-methyltransferase 2 (SHMT2), participating in the synthesis of mitochondrial thymidine monophosphate, has been reported to drive glioma cell survival in ischemia. However, its clinical relevance in gliomas remains unclear. In the current study, immunohistochemistry was...
Autores principales: | Wu, Ming, Wanggou, Siyi, Li, Xuejun, Liu, Qing, Xie, Yuanyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538688/ https://www.ncbi.nlm.nih.gov/pubmed/28794642 http://dx.doi.org/10.2147/OTT.S130409 |
Ejemplares similares
-
miR-526b-3p serves as a prognostic factor and regulates the proliferation, invasion, and migration of glioma through targeting WEE1
por: Wu, Ming, et al.
Publicado: (2019) -
Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker
por: Zhang, Lahong, et al.
Publicado: (2016) -
Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
por: Zou, Han, et al.
Publicado: (2020) -
Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma
por: Wanggou, Siyi, et al.
Publicado: (2016) -
Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas
por: Yu, Shoukai
Publicado: (2022)